CCC Intelligent Solutions (CCC) Q1 2026 earnings review
Steady Top-Line, Surging Margins, but Liquidity Shrinks
CCC delivered a textbook 'beat and raise' quarter. Revenue grew a stable 12% YoY, and Adjusted EBITDA margins expanded nearly 400 basis points to 43%. The operational milestone of the quarter was GAAP Net Income turning positive ($15.4M) after heavy stock-based comp weighed on prior years. However, aggressive capital returns—$400M in share repurchases in Q1 alone—drained the cash balance to just $36.9M against a $1.3B debt load. While the cross-selling engine is executing flawlessly, the balance sheet suddenly leaves less room for error.
🐂 Bull Case
Top-5 insurers are moving from pilot to enterprise-wide production. Q1 saw two separate top-5 carriers sign major multi-year expansions for the Auto Physical Damage (APD) AI suite and the Casualty platform.
Adjusted EBITDA margin held at an impressive 43%, and GAAP profitability was achieved as R&D and stock-based compensation normalized.
🐻 Bear Case
Following $400M in Q1 share repurchases, the cash balance plummeted to $36.9M. With $1.3B in debt, the company relies entirely on ongoing cash flow generation to maintain flexibility.
Despite Adjusted EBITDA jumping 21% YoY, Free Cash Flow slightly declined to $41.6M from $43.6M a year ago, hindered by working capital timing and high interest expenses.
⚖️ Verdict: 🟢
Bullish. The software platform is incredibly sticky, and the shift of large insurers migrating their Casualty operations to CCC provides a massive runway. The debt load is a point for monitoring, but the recurring revenue profile mitigates the risk.
Key Themes
AI and Casualty Land Mega-Deals
Accelerating. The strategic shift toward cross-selling is paying off with the largest customers. A top-5 insurer expanded its relationship with a multi-year enterprise agreement for the full AI-enabled APD suite. Simultaneously, a different top-5 insurer signed a multi-year deal to move a significant portion of its Casualty operations to CCC. This validates management's prior claims that Casualty could eventually rival APD in scale.
Aggressive Buybacks Squeeze Liquidity
Reversing. CCC completed a massive $300M Accelerated Share Repurchase (ASR) and followed it up with an additional $100M in open-market buys during Q1. While this signals immense board confidence, it caused cash and cash equivalents to collapse from $111.2M at the end of FY25 to just $36.9M. Total debt remains elevated at $1.28B. Leverage is now highly dependent on flawless quarterly execution.
Free Cash Flow Disconnect
Decelerating. Adjusted EBITDA surged 21% YoY to $120.2M, but Free Cash Flow actually slipped to $41.6M (down from $43.6M in 25Q1). This decoupling was driven by working capital headwinds—specifically a $25.1M reduction in accrued expenses—and heavy debt servicing ($20.3M in GAAP interest expense). Operations are generating profit, but working capital and interest are eating the cash.
Macro Claim Volumes
Stable. While not explicitly quantified in the Q1 press release, industry-wide auto physical damage claim volumes have been a persistent ~1% headwind to revenue growth over the last four quarters. CCC's ability to print 12% revenue growth despite lower industry claim frequency highlights the resilience of its 85% subscription-based revenue model.
Other KPIs
Reversing. Flipped dramatically from a $17.4M loss in the prior year. This was primarily driven by gross profit expansion ($23.8M increase) and a significant reduction in operating expenses, particularly R&D, as previous spikes in stock-based compensation began to normalize.
Decelerating. Dropped from $61.8M in 25Q1. This 15% reduction illustrates the operating leverage embedded in the business model. After heavily investing in the AI architecture and digesting the EvolutionIQ acquisition, CCC is now scaling the platform without proportionally adding headcount or software development costs.
Guidance
Accelerating. The midpoint of $1.159B implies a 9.6% YoY growth rate. More importantly, management raised this range from the $1.147 - $1.157 billion forecast given just one quarter ago, reflecting high visibility into enterprise contract ramps.
Accelerating. Raised from the previous $477.0 - $485.0 million outlook. The midpoint of $487M implies an annual margin of roughly 42%.
Decelerating. Implies roughly 8.5% to 9.5% YoY growth, a step down from the 12% growth delivered in Q1. This likely factors in conservative assumptions regarding implementation timelines or continued industry claims pressure.
Decelerating. The midpoint ($112M) implies a sequential margin compression to ~39.4% from the 43.0% achieved in Q1. This suggests potential seasonal hiring, phasing of professional services, or upfront costs tied to the new top-5 insurer Casualty implementations.
Key Questions
Sequential Margin Compression
Q2 guidance implies Adjusted EBITDA margins dropping from 43% in Q1 to roughly 39.4%. Is this compression driven by upfront integration costs for the newly announced top-5 insurer deals, or is it a structural phasing of hiring?
Liquidity Strategy
With the cash balance down to $36.9M following Q1 repurchases and $100M remaining on the authorization, how will the company fund further buybacks or strategic M&A without drawing on the revolver?
EvolutionIQ Impact on Casualty Wins
To what extent did the integration of EvolutionIQ's Medhub technology tip the scales in winning the new top-5 insurer Casualty mandate?
Working Capital Normalization
Operating cash flow was weighed down by a $25M reduction in accrued expenses this quarter. Do you expect working capital to normalize in Q2, allowing Free Cash Flow growth to better mirror EBITDA growth?